Sage Therapeutics currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here . Cytokinetics Stock Up on Pipeline Update ...

Third-quarter figures were not inspiring to investors. The biotech missed rather badly on both the top and bottom lines. For the quarter, Sage posted revenue that landed just shy of $2.72 million ...

Biotech Stock Roundup: SAGE Up on Declining BIIB's Offer, CYTK, AKRO Up on Updates January 29, 2025 — 12:02 pm EST. Written by Zacks Equity Research for ...